Oncolytics Achieves Success Criteria for Efficacy in the Third-Line Colorectal Cancer Cohort of the GOBLET Study

Oncolytics Biotech® Inc. Canada United States of America New York California Alberta

View original content:https://www.prnewswire.co.uk/news-releases/oncolytics-achieves-success-criteria-for-efficacy-in-the-third-line-colorectal-cancer-cohort-of-the-goblet-study-301964257.html